CN Patent
CN102336702A — Xa因子抑制剂n-(5-氯-2-吡啶基)-2-[[4-[(二甲氨基)亚氨基甲基]苯甲酰基]氨基]-5-甲氧基-苯甲酰胺的医药盐和多晶型
Assigned to Millennium Pharmaceuticals Inc · Expires 2012-02-01 · 14y expired
What this patent protects
本发明提供一种盐,其包含式(I)化合物和具有抗哺乳动物因子Xa的活性的酸。本发明也涉及制备所述式(I)化合物的方法。
USPTO Abstract
本发明提供一种盐,其包含式(I)化合物和具有抗哺乳动物因子Xa的活性的酸。本发明也涉及制备所述式(I)化合物的方法。
Drugs covered by this patent
- Bevyxxa (BETRIXABAN) · Portola Pharms Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.